Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €55.23 EUR
Change Today +2.35 / 4.44%
Volume 80.0
8AK On Other Exchanges
As of 3:32 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Kathryn L. Biberstein

Chief Compliance Officer, Chief Legal Officer, Senior Vice President and Secretary,Alkermes plc
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Ms. Kathryn L. Biberstein, also known as Kathy has been Senior Vice President and Chief Compliance Officer of Alkermes plc since May 2007. Ms. Biberstein has been Secretary of Alkermes plc since June 2004 and its Chief Legal Officer since September 2011. Ms. Biberstein served as a General Counsel of Alkermes plc from March 2003 to September 2011. She served as a Vice President of Alkermes plc from March 2003 to May 22, 2007. She served as a Senior Vice President of ...

Read Full Background

Corporate Headquarters*

Connaught House
Dublin, Co. Dublin 4


Phone: 353 1 772 8000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


Kettering University
The University of Michigan Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$459,389

Stock Options*

Restricted Stock Awards$660,240
All Other Compensation$13,000
Exercised Options79,004
Exercised Options Value$3,099,365
Exercisable Options485,429
Exercisable Options Value$21,159,907
Unexercisable Options206,500
Unexercisable Options Value$5,723,475
Total Value of Options$29,982,746
Total Number of Options770,933

Total Compensation*

Total Annual Cash Compensation$933,009
Total Short Term Compensation$459,389
Other Long Term Compensation$673,240
Total Calculated Compensation$3,040,997
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
8AK:GR €55.23 EUR +2.35


David M. Stack Chairman, Chief Executive Officer and President
Pacira Pharmaceuticals, Inc.
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
Daniel J. Abdun-Nabi Chief Executive Officer, President, Director, Member of Strategic Operations Committee and Member of Pricing Committee
Emergent BioSolutions, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ALKERMES PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at